Business
Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine
Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, and Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced a nonexclusive collaboration to develop AI-based companion diagnostic solutions. The collaboration will leverage Lunit's AI technology and Agilent's expertise in tissue-based companion diagnostics to create advanced solutions that meet the demand of novel and complex biomarker
About this update from Lunit Inc.
[{"type":"text","content":"Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities ","length":167,"tagName":"p"},{"type":"text","content":"SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, and Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced a nonexclusive collaboration to develop AI-based companion diagnostic solutions. The collaboration will leverage Lunit's AI technology and Agilent's expertise in tissue-based companion diagnostics to create advanced solutions that meet the demand of novel and complex biomarker assays in drug development.","length":587,"tagName":"p"},{"type":"image","alt":"Lunit and Agilent Technologies announce a collaboration to develop AI-powered companion diagnostics. (Courtesy of Lunit)","displaySize":"","headline":null,"caption":"Lunit and Agilent Technologies announce a collaboration to develop AI-powered companion diagnostics. (Courtesy of Lunit)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":222,"url":"https://media.zenfs.com/en/prnewswire.com/b6905755f5efd4f99fbf471711a3ee5c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OUW14Wor.fk7NS.30x07tQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b6905755f5efd4f99fbf471711a3ee5c","width":400,"height":222}},"href":"https://mma.prnewswire.com/media/2778296/Lunit_Agilent_Technologies_announce_a_collaboration_develop_AI_powered_companion_diagnostics.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Under this agreement, Lunit and Agilent will develop advanced AI-powered companion diagnostic tools designed to enhance the accuracy of diagnosis and the measurement of therapeutic efficacy. The initial focus will be on leveraging Lunit's AI algorithms with Agilent's state-of-the-art assays to evaluate biomarkers critical for the development of new pharmaceutical therapies.","length":389,"tagName":"p"},{"type":"text","content":"The joint solutions will support pharmaceutical companies in companion diagnostic (CDx) product development, improving the precision and accuracy of biomarker t...